121 results
6-K
EX-99.1
CANF
Can-Fite Biopharma Ltd
22 May 24
2024 Annual General Meeting of Shareholders
4:15pm
or by a general meeting of our shareholders prior to the expiration of their term of office. The directors do not receive any benefits upon
POS AM
CANF
Can-Fite Biopharma Ltd
5 Apr 24
Prospectus update (post-effective amendment)
4:15pm
shareholders prior to the expiration of their term of office. The directors do not receive any benefits upon the expiration of their term of office
6-K
EX-99.1
CANF
Can-Fite Biopharma Ltd
3 Apr 24
Report of Foreign Private Issuer
7:07am
hepatic steatosis and fibrosis which may provide important therapeutic benefits for patients.”
Rates of MASH are increasing in the United States
F-3/A
viwfh267bk
28 Dec 23
Shelf registration (foreign) (amended)
4:16pm
F-3
k67ftsx pl
12 Dec 23
Shelf registration (foreign)
4:15pm
6-K
EX-10.1
vbi8csx pen
22 Nov 23
Report of Foreign Private Issuer
4:15pm
6-K
EX-99.1
0okhlqw7jr6zuo0cw0
7 Sep 23
Report of Foreign Private Issuer
7:25am
POS AM
34j6uaqnz b3vw
1 Sep 23
Prospectus update (post-effective amendment)
4:16pm
F-3
gxyc0r9l3n4 zx15
1 Sep 23
Shelf registration (foreign)
4:15pm
F-3
EX-5.1
yp6h5a 5qzfd49gn96y
1 Sep 23
Shelf registration (foreign)
4:15pm
6-K
EX-99.1
c42v6ga8etfsu inv
23 Jun 23
2023 Annual General Meeting of Shareholders
4:15pm
POS AM
3v8u 3e64fgp4jzrg29
21 Apr 23
Prospectus update (post-effective amendment)
4:16pm
POS AM
brdmh7knpqz6q3ya
31 Mar 23
Prospectus update (post-effective amendment)
4:30pm
POS AM
be2u sd99n1a6z2m2
26 Aug 22
Prospectus update (post-effective amendment)
4:31pm
6-K
EX-99.1
9ejjbgn19aq 0qv6mn
25 Jul 22
Report of Foreign Private Issuer
4:30pm